| Literature DB >> 35112588 |
Mohammad Ali Alghafees1, Abdullah Abdulmonen2,3, Mahmoud Eid2,3, Ghadah Ibrahim Alhussin1, Mohammed Qasem Alosaimi1, Ghadah Saad Alduhaimi1, Mohammed Talal Albogami1, Mohammed Alhelail2,3.
Abstract
BACKGROUND: Acute poisoning is a major contributing factor to mortality and morbidity. There is a lack of research on the epidemiology of acute poisoning risk factors in Saudi Arabia.Entities:
Mesh:
Year: 2022 PMID: 35112588 PMCID: PMC8812162 DOI: 10.5144/0256-4947.2022.36
Source DB: PubMed Journal: Ann Saudi Med ISSN: 0256-4947 Impact factor: 1.526
Body weight profile of the study population (n=1505).
| Adults (n=492) | Children (n=1013) | |
|---|---|---|
| Underweight | 260 (52.8) | 629 (62.1) |
| Normal weight | 114 (23.2) | 189 (18.7) |
| Overweight | 63 (12.8) | 117 (11.5) |
| Obesity class 1 | 30 (6.1) | |
| Obesity class 2 | 20 (4.1) | 78 (7.7) |
| Obesity class 3 | 5 (1.0) |
Data are number (%). Underweight: <18.5 kg/m2, Normal weight: 18.5–24.9 kg/m2, Overweight: 25.0–29.9 kg/m2, Obesity class 1: 30–34.9 kg/m2, Obesity class 2: 35–39.9 kg/m2, Obesity class 3: ≥40 kg/m2.
Children not classified by obesity class.
Medical history of the study population.
| Medical history | Adults (n=496) | Children (n=1013) |
|---|---|---|
| No comorbidities | 360 (73.2) | 774 (76.4) |
| Neuropsychiatric disorder | 51 (10.4) | 76 (7.5) |
| Cardiovascular disease | 33 (6.7) | 54 (5.3) |
| Diabetes mellitus | 27 (5.5) | 43 (4.2) |
| Bronchial asthma | 20 (4.1) | 36 (3.6) |
| Metabolic disorder | 13 (2.6) | 23 (2.3) |
| Attention deficit hyperactivity disorder | 7 (1.4) | 13 (1.3) |
| Cerebrovascular disease | 6 (1.2) | 6 (0.6) |
| Renal disease | 6 (1.2) | 17 (1.7) |
| Autism spectrum disorder | 5 (1.0) | 7 (0.7) |
| Hematologic disease | 5 (1.0) | 5 (0.5) |
| Endocrine disorder | 4 (0.8) | 11 (1.1) |
| Congenital heart disease | 3 (0.6) | 13 (1.3) |
| Developmental delay | 3 (0.6) | 15 (1.5) |
| Down syndrome | 3 (0.6) | 7 (0.7) |
| Pulmonary disease | 3 (0.6) | 4 (0.4) |
| Congenital neurological defects | 2 (0.4) | 10 (1.0) |
| Cancers | 2 (0.4) | 7 (0.7) |
| Autoimmune diseases | 2 (0.4) | 5 (0.5) |
| Liver disease | 2 (0.4) | 8 (0.8) |
| Ophthalmic disease | 2 (0.4) | 4 (0.4) |
| Benign prostatic hyperplasia | 1 (0.2) | 2 (0.2) |
| Gastroenterological disease | 1 (0.2) | 6 (0.6) |
| Musculoskeletal disorder | 2 (0.4) | 6 (0.6) |
Data are number (%).
Poisoning history of the adults and children.
| Adults (n=492) | Children (n=1013) | |
|---|---|---|
| Number of poison agents consumed | ||
| 1 | 411 (83.5) | 854 (84.3) |
| 2 | 49 (10.) | 107 (10.6) |
| 3 | 22 (4.5) | 28 (2.8) |
| 4 | 4 (0.8) | 14 (1.4) |
| 5 | 3 (0.6) | 5 (0.5) |
| 6 | 2 (0.4) | 3 (0.3) |
| 7 | 1 (0.2) | 1 (0.1) |
| Discharge status | 1 (0.1) | |
| Mature | 478 (97.2) | 990 (97.7) |
| Premature | 14 (2.8) | 23 (2.3) |
| Outcome status | ||
| Uneventful | 455 (92.5) | 957 (94.5) |
| Intensive care unit admission | 33 (6.7) | 49 (4.8) |
| Organ transplantation | 1 (0.1) | |
| Death | 4 (0.8) | 3 (0.3) |
| Not documented | 3 (0.3) |
Data are number (%).
Clinical presentation of poisoning in the adults (n=492).
| Asymptomatic | 214 (43.5) |
| Altered level of consciousness | 95 (19.3) |
| Vomiting | 67 (13.6) |
| Abdominal pain | 43 (8.7) |
| Dizziness | 39 (8.0) |
| Diaphoresis | 32 (6.5) |
| Palpitation, tachycardia | 30 (6.1) |
| Headache | 25 (5.1) |
| Agitation | 23 (4.7) |
| Chest pain | 15 (3.0) |
| Partial seizure | 14 (2.9) |
| Generalized weakness, lethargy | 13 (2.6) |
| Nausea | 12 (2.4) |
| Bleeding | 9 (1.8) |
| Salivation | 8 (1.6) |
| Cough | 7 (1.4) |
| Tremor | 6 (1.2) |
| Ataxia (unsteady gait) | 6 (1.2) |
| Body ache, generalized pain | 4 (0.8) |
| Diarrhea | 4 (0.8) |
| Dystonic reaction, Dyskinesia | 4 (0.8) |
| Hypertension | 4 (0.8) |
Data are number (%). Other less frequent presentations included constipation, diplopia (visual disturbance), dysarthria (slurred speech), fever, hallucinations.
Clinical presentation of poisoning in the children (n=1013).
| Asymptomatic | 554 (54.7) |
| Altered level of consciousness | 134 (13.2) |
| Vomiting | 113 (11.2) |
| Abdominal pain | 66 (6.5) |
| Dizziness | 59 (5.8) |
| Shortness of breath | 44 (4.3) |
| Agitation | 43 (4.2) |
| Headache | 41 (4.0) |
| Palpitation, tachycardia | 39 (3.9) |
| Nausea | 32 (3.2) |
| Chest pain | 20 (2.0) |
| Ataxia (unsteady gait) | 17 (1.7) |
| Generalized weakness, lethargy | 17 (1.7) |
| Dystonic reaction, Dyskinesia | 15 (1.5) |
| Seizure | 15 (1.5) |
| Diarrhea | 14 (91.4) |
| Bleeding | 12 (1.2) |
| Cough | 12 (1.2) |
| Tremor | 10 (1.0) |
| Diplopia (visual disturbance) | 9 (0.9) |
| Paresthesia | 7 (0.7) |
| Rash | 7 (0.7) |
Data are number (%). Other less frequent presentations included rash, diaphoresis, hallucinations, fever, salivation, throat pain, cyanosis, and others
Interventions provided for the adult and child sample (n=1505).
| Intervention | Adults (n=492) | Children (n=1013) |
|---|---|---|
| Observation and supportive management (total) | 419 (85.1) | 901 (88.92) |
| Observation and reassurance | 298 (60.7) | 677 (66.81) |
| Supportive and symptomatic management | 84 (17.0) | 168 (16.58) |
| Admission | 37 (7.4) | 56 (5.53) |
| Decontamination and elimination (total) | 50 (10.2) | 94 (9.28) |
| Activated charcoal | 38 (7.7) | 85 (8.39) |
| Multi-dose activated charcoal | 1 (0.2) | |
| Decontamination | 5 (1.0) | 4 (0.39) |
| Gastric lavage | 3 (0.6) | 1 (0.10) |
| Dialysis | 2 (0.4) | 3 (0.30) |
| Lipid emulsion | 1 (0.2) | |
| Urine alkalinization | 1 (0.10) | |
| Antidotal and targeted therapy (total) | 78 (15.6) | 95 (9.37) |
| Benzodiazepine | 26 (5.2) | 29 (2.86) |
| N-acetylcysteine | 15 (3.1)) | 22 (2.17) |
| Vitamin K | 6 (1.2) | 4 (0.39) |
| Atropine | 5 (1.0) | 8 (0.79) |
| Naloxone | 5 (1.0) | 7 (0.69) |
| Pralidoxime | 4 (0.8) | 1 (0.10) |
| Benztropine (anticholinergics) | 3 (0.6) | 1 (0.10) |
| Thiamine | 3 (0.6) | |
| Sodium bicarbonate | 3 (0.6) | 4 (0.39) |
| Diphenhydramine | 2 (0.4) | 5 (0.49) |
| Phenytoin | 1 (0.2) | |
| Haloperidol | 1 (0.2) | |
| Furosemide | 1 (0.2) | |
| Inotropes | 1 (0.2) | |
| Ketamine | 1 (0.2) | |
| Vasopressors | 4 (0.39) | |
| Deferoxamine | 1 (0.10) | |
| Fomepizole | 3 (0.30) | |
| Glucagon | 1 (0.10) | |
| Hydroxocobalamin | 1 (0.10) | |
| Heparin | 1 (0.10) | |
| Flumazenil | 2 (0.20) | |
| Ethanol | 1 (0.10) | |
| Blood and blood products (total) | 4 (0.8) | 5 (0.49) |
| Blood transfusion | 1 (0.2) | |
| Fresh frozen plasma | 3 (0.6) | 5 (0.49) |
| Miscellaneous (total) | 22 (4.5) | 33 (3.26) |
| Intubation | 12 (2.4) | 15 (1.48) |
| Cardio-pulmonary resuscitation | 1 (0.2) | |
| Not documented | 9 (1.8) | 17 (1.68) |
Data are number (%)